EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Comparative Analysis of BRCA Pathogenic Variant Detection in a Real-World Setting: Population Screening Versus Oncogenetic Clinics

Shunit Armon iD, Sari Lieberman iD, Rachel Michaelson-Cohen, Ariela Tomer, Einat Koller-Volkow, Ephrat Levy-Lahad iD, Naama Srebnik

JCO Precision Oncology · 2026-04 · 10 (4)

DOI: 10.1200/po-25-01023 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift JCO Precision Oncology, 2026-04. Verfasst von Shunit Armon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Shaare Zedek Medical Center, Jerusalem, Israel. Hauptthemen laut MEDLINE: BRCA2 Protein, BRCA1 Protein, Genetic Testing, Ovarian Neoplasms. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Israel has pioneered population-wide screening (PS) for BRCA pathogenic variants (PVs). We aimed to compare psychosocial aspects and outcomes of carriers identified through PS versus via oncogenetic clinics (OC) in a real-world setting. METHODS A cohort study conducted at BRCA high-risk surveillance clinic in Shaare Zedek Medical Center Jerusalem, Israel (9.2021-5.2024). Data were obtained from electronic medical records and self-reported questionnaires. The study included newly identified unaffected female BRCA1/2 PV carriers: PS carriers received only post-test genetic counseling, whereas OC carriers received both pre- and post-test counseling. RESULTS We identified 352 carriers: 202 PS and 150 OC. Sociodemographic characteristics were similar. PS carriers harbored more BRCA2 -PVs (62.9% v 48.7%, P = .001) rather than BRCA1 -PVs, and fewer had suggestive family history (FH) (40.4% v 61%, P < .001). In univariate analysis, both groups reported satisfaction with pretest information. PS carriers reported lower satisfaction with result delivery: (3.3 ± 1.3 v 3.9 ± 1.2 [scale 1-5]; P = .001) and health decisions: (24.6 ± 3.9 v 25.9 ± 3.6 [scale 6-30]; P = .014). However, testing mode was not predictive of psychosocial outcomes in multivariate analysis. Risk-reducing bilateral salpingo-oophorectomy (RR-BSO) rates at recommended age were similar in PS and OC: BRCA1 ≥40 years: 74.1% versus 85.7%, BRCA2 ≥45 years: 81.4% versus 63.5%, respectively. CONCLUSION In a real-world setting, PS identified carriers with less FH and more BRCA2 -PVs. PS was associated with favorable psychosocial outcomes and high RR-BSO uptake. The process requires refinement and long-term evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BRCA2 ProteinBRCA1 ProteinGenetic TestingOvarian NeoplasmsHumansFemaleMiddle AgedAdultIsraelCohort StudiesGenetic CounselingGenes, BRCA2

Substanzen

BRCA2 ProteinBRCA1 ProteinBRCA2 protein, humanBRCA1 protein, human

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Shaare Zedek Medical Center, Jerusalem, Israel.
  • The Eisenberg R&D Authority, Shaare Zedek Medical Center, Jerusalem, Israel.
  • Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
  • The Fuld Family Medical Genetics Institute, Shaare Zedek Medical Center, Jerusalem, Israel.

ORCID-Profile: Shunit Armon, Sari Lieberman, Ephrat Levy-Lahad

Zitieren

APA

Armon, S., Lieberman, S., Michaelson-Cohen, R., Tomer, A., Koller-Volkow, E., Levy-Lahad, E., & Srebnik, N. (2026). Comparative Analysis of BRCA Pathogenic Variant Detection in a Real-World Setting: Population Screening Versus Oncogenetic Clinics. JCO Precision Oncology, 10(4). https://doi.org/10.1200/po-25-01023

Vancouver

Armon S, Lieberman S, Michaelson-Cohen R, Tomer A, Koller-Volkow E, Levy-Lahad E, et al. Comparative Analysis of BRCA Pathogenic Variant Detection in a Real-World Setting: Population Screening Versus Oncogenetic Clinics. JCO Precision Oncology. 2026;10(4). doi:10.1200/po-25-01023

BibTeX
@article{Armon2026,
  author = {Armon, Shunit and Lieberman, Sari and Michaelson-Cohen, Rachel and Tomer, Ariela and Koller-Volkow, Einat and Levy-Lahad, Ephrat and Srebnik, Naama},
  title = {Comparative Analysis of BRCA Pathogenic Variant Detection in a Real-World Setting: Population Screening Versus Oncogenetic Clinics},
  journal = {JCO Precision Oncology},
  year = {2026},
  volume = {10},
  number = {4},
  doi = {10.1200/po-25-01023}
}
Kostenlos starten →